Recent Headlines
Within Biotechnology

MiTeGen Opens NANUQ Access Facility

MiTeGen LLC, a provider of innovative consumables and equipment for protein crystallization and single crystal X-ray, announced the opening of the NANUQ Access Facility (NAF) which provides scientists with day-use access to MiTeGen’s revolutionary automated high-speed cryocooling device (NANUQ). - April 12, 2017 - MiTeGen, LLC

Tactiva Therapeutics Reports Data Highlighting a Novel Dual CD4/CD8 T Cell Receptor with Potential for Use Against a Broad Range of Cancers

Tactiva Therapeutics today reported on its unique, dual enhanced adoptive cell therapy (DEACT) platform, incorporating its proprietary, engineered CD4/CD8 T cell receptors (TCR) with potential broad utility in cancer immunotherapy, including melanoma and ovarian cancer. A late breaking abstract... - April 05, 2017 - Tactiva Therapeutics

MoBiTec GmbH to Attend LABVOLUTION/ BIOTECHNICA, May 16-18, 2017, Hannover, Germany

LABVOLUTION with BIOTECHNICA is a fully integrated event that provides a multidisciplinary perspective on all aspects of the laboratory world. Don't miss Northern Europe's leading business platform for laboratory technology and biotechnology. - March 31, 2017 - MoBiTec GmbH

Captozyme Secures $3.4 Million to Continue Enzyme Research

Captozyme, a biotechnology company, recently raised $3.4 million to manufacture and launch their oxalate-degrading enzyme, Nephure, to facilitate those on a low-oxalate diet. - March 27, 2017 - Captozyme

Jivana Biotechnology Inc, is Pleased to Announce the Addition of Dr. Ajay Maker to Its Advisory Committee

Dr. Maker brings surgical oncology experience with expertise in liver, gallbladder. colon, pancreatic, and other cancers to Jivana Biotechnology's advisory committee. - March 16, 2017 - Jivana Biotechnology Inc

AdvantaPure(R) Launches AdvantaSil(TM) Brand of Silicone Tubing and Hose

AdvantaPure has rebranded its silicone tubing and reinforced hose under the AdvantaSil name. The products, used primarily for biopharm and pharmaceutical Single-Use processes, have been depended upon by design engineers for years. AdvantaSil products include unreinforced tubing, reinforced hose, pump grade tubing and wire reinforced suction hose. - March 16, 2017 - AdvantaPure

Novel Lipid Research Assay: Lysosomal PLA2 Inhibitor Screen

Inhibition of Lysosomal phospholipase A2 (LPLA2) by a drug candidate can predict its potential to cause drug-induced phospholipidosis, a serious side effect resulting in tissue inflammation and organ damage. - March 11, 2017 - MoBiTec GmbH

MR Solutions Introduces 9.4T Preclinical MRI Imaging Solution to Cardiovascular Sector

MR Solutions’ new 9.4 tesla cryogen free preclinical scanners created great interest from cardiologists at the 20th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR). - March 08, 2017 - MR Solutions

MagCore DNA Extraction and Purification Technology Now Available in the US

The MagCore® nucleic acid extraction and purification system is now available through Parallel Devices, a supplier of life science sample preparation products. - March 07, 2017 - Parallel Devices

Regulatory and Compliance Resources, Inc. Opens New Office in the Denver Metro Area

Pharmaceutical, Bio-pharmaceutical drug manufacturing consulting and talent resourcing company expands operations in the growing Denver market. - March 01, 2017 - Regulatory and Compliance Resources, Inc.

Kemwell Announces Successful USFDA Inspection at Bangalore Facility

Kemwell Biopharma, a global bio/pharmaceutical contract development and manufacturing company, announced today that its oral solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection. The inspection confirmed the... - February 19, 2017 - Kemwell Biopharma Private Limited

Virun® Releases STATIC™ Episode 2 While Under the Influence of Sulfur Hexaflouride, and New Probiotic Technology Makes Wholefoods Take Notice

Virun® NutraBiosciences® Ongoing Video Series Explores the Smells of Stability and Voice-changing Gases; Virun’s Patent & Patents-pending Non-refrigerated Shelf-stable Probiotics Become Available to Manufacturers Worldwide - February 14, 2017 - VIRUN

Zifo RnD Solutions Ranked Number 350 Fastest Growing Technology Company on the Deloitte Technology Fast 500™ Asia Pacific 2016

Zifo RnD Solutions today announced that it ranked Number 350 on the Deloitte Technology Fast 500™ Asia Pacific 2016, a ranking of the 500 fastest growing technology companies in Asia Pacific. Rankings are based on percentage revenue growth over three years. Zifo RnD Solutions grew 146 percent... - February 02, 2017 - Zifo

Bioscience Americas Unveils New, Patient Focused Website

New website allows prospective patients to sign-up for autologous stem cell therapies at the Company's Colombia location. - January 30, 2017 - Bioscience Americas

NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. Sign Licensing Agreement for Hemorrhagic Shock and Perioperative Blood Loss

NuvOx Pharma LLC and Jiangsu Nhwa Pharmaceutical Co., Ltd. have signed a licensing agreement for the exclusive development and sales of NVX-408 for China for treating hemorrhagic shock and perioperative blood loss. NVX-408 is an oxygen therapeutic that is injected intravenously, flows through the... - January 26, 2017 - NuvOx Therapeutics

G&L Scientific Inc. Announces Opening of New Offices in Cambridge, Massachusetts

G&L Scientific Inc, the leading provider of clinical and scientific consulting and resource to the healthcare industry (http://www.gandlscientific.com), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving access to its expanding team of clinical and scientific consultants and contractors. This is the latest step in G&L’s expansion of its global clinical consulting services throughout the United States. - January 19, 2017 - G&L Scientific Inc

Dr. Shekhar Challa Joins Bioscience Americas Board of Advisors

Co-Founder of the Kansas Medical Clinic is a renowned gastroenterologist. - January 13, 2017 - Bioscience Americas

The Zoozler Venture Network is Looking for an Idea

You have a fantastic idea for a product or service but you don't know how to go about making it a reality. You know that you'll need investors but how do you get to them? That's where the Zoozler Venture Network can help. The Zoozler Venture Network will take the idea and help make it into a successful reality. - January 13, 2017 - Zoozler

Prefilled Syringes Market to Grow at 3.9% Annually, Predicts Roots Analysis

Roots Analysis has announced the addition of the “Prefilled Syringes Market (4th Edition), 2017-2026” report to its list of offerings. The report provides a comprehensive analysis of the current state and the likely future evolution of the prefilled syringes market. It provides details... - January 08, 2017 - Roots Analysis

Bioscience Americas Names Addition to Its Board of Advisors

Dr. Firas M. Kara joins Board to assist with Bioscience Americas international development efforts. - January 03, 2017 - Bioscience Americas

Immune Response Bio FDA BLA Update HIV Clinicians "Remune Repeatedly Immunogenic"

Immune Response Bio Update HIV Clinicians Verify "Remune Repeatedly Immunogenic" - December 30, 2016 - Immune Response BioPharma, Inc.

3D Map of PC2 to Jump-Start Drug Discovery Efforts in Polycystic Kidney Disease

Scientists from the Structural Genomics Consortium (SGC) and Oxford University report a three-dimensional view of the Polycystin-2 (PC2), a protein that causes autosomal dominant polycystic kidney disease (ADPKD) when mutated, in an article published this week in Nature Structural and Molecular... - December 21, 2016 - The SGC

Thrivous Joins the Tech Inclusion Pledge

Thrivous, a human enhancement company, has joined the Tech Inclusion Pledge as announced by President Obama. At the Global Entrepreneurship Summit this past summer, President Obama announced a commitment by senior leadership from 33 companies of all sizes to fuel American innovation and economic... - December 18, 2016 - Thrivous

Fierce Innovation Awards: Life Sciences Edition Announce Finalists, Innovative Biochips Recognized

Innovative Biochips LLC has been selected as a finalist in Fierce Innovation Awards 2016 for its innovative product, Automated Yeast Aging Analysis System. - December 15, 2016 - Innovative Biochips

Bioscience Americas Lauds Passage of the 21st Century Cures Act

President Obama is expected to sign this landmark bi-partisan legislation soon. - December 13, 2016 - Bioscience Americas

Stem Cells Can Successfully Treat Patients with Type 1 Diabetes

The Bioscience Americas science team has a 5-year, 76% remission rate treating Type 1 diabetes using a patient's own stem cells. - December 08, 2016 - Bioscience Americas

University of Malaga Researchers Collaborate with AST to Develop New Lignin-Based Products

AST to send multiple shipments of its Organosolv lignin for continued product development efforts. - December 07, 2016 - American Science and Technology

Life Science Leader and ClinicalLeader.com Announce New Forum for Small to Mid-Sized Pharma and Biotech Companies

Life Science Leader and ClinicalLeader.com are excited to introduce Clinical Leader Forum, a new conference tailored just for executives at pharma and biotech sponsor companies that rely on contract research organizations for clinical trials. The inaugural event is scheduled for May 10 through 11... - December 07, 2016 - Clinical Leader Forum

New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs

New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC

Research to be Presented at ASH Annual Meeting Shows Verseon’s New Class of Anticoagulants Prevents Thrombosis While Preserving Platelet Function

Verseon’s anti coagulants are as effective as NOACS at preventing arterial and venous thromboembolism and thrombin-induced pulmonary embolism. Lead candidate has low renal clearance compared to NOACS - highly desirable for patients with impaired renal function. - November 30, 2016 - Verseon

Global Cancer Technology, Inc. Signs Licensing Agreement with the University of California San Diego

Announcing an agreement to purchase patent and IP technology from UCSD for a novel way to track medical instruments using Nano Quantum Dots - November 25, 2016 - Global Cancer Technology, Inc

Zifo RnD Solutions Ranked Number 40 Fastest Growing Technology Company on the Deloitte Technology Fast 50™ India 2016

Attributes its 146% revenue growth to the Zifo team’s collective strength and commitment towards customer’s success. - November 23, 2016 - Zifo

Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults

A new transdermal gel has been developed and is now available by prescription only to treat the symptoms of gout attacks. ColciGel® is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems. - November 22, 2016 - Gensco Pharma

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds

Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications. - November 19, 2016 - Gensco Pharma

Mount Sinai Beth Israel Receive Award from the Department of Defense to Study Gulf War Illness with electroCore’s Non-Invasive Vagus Nerve Stimulation Therapy

The Pain & Fatigue Study Center at Mount Sinai Beth Israel in New York has been awarded a United States Army Medical Research grant to conduct a study into the treatment of veterans of the 1990-1991 Gulf War who have Gulf War Illness using electroCore’s non-invasive vagus nerve... - November 17, 2016 - electroCore

New Gastrointestinal Pathogen Assays Available from ALPCO

ALPCO is now offering a line of research assays for the investigation of common bacterial and parasitic gastrointestinal (GI) pathogens including Giardia lamblia, Cryptosporidium spp., Blastocystis hominis, Entamoeba histolytica/dispar, and Clostridium difficile. These assays can be used to... - November 15, 2016 - ALPCO

Virun® Launches a Line of Shelf-Stable Probiotic Multi-Serving Powders and Emulsions

Virun® NutraBiosciences® Technology Revolutionizes Probiotics with Non-refrigerated Probiotic Single-serving Powders and Emulsions Available to Manufacturers. - November 15, 2016 - VIRUN

New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1

ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016 - ALPCO

NuvOx Pharma Awarded NIH Grant to Develop Technology to Increase Sensitivity and Specificity of Breast Cancer Diagnosis

NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, “B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer.” Evan Unger, MD, co-founder of NuvOx, a co-principal investigator of the... - November 03, 2016 - NuvOx Therapeutics

Viral Vectors and Plasmid DNA Manufacturing to Witness 16% Annual Growth, Predicts Roots Analysis

Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapidly growing market of gene therapy vectors. Kashish Goel, the principal analyst, said, “Gene... - November 02, 2016 - Roots Analysis

Thrivous Launches Serenity, the Nightly Nootropic

Thrivous, a human intelligence and vitality company, has developed and brought to market Serenity, the nightly nootropic. Serenity is designed for nightly use to promote calm and sleep, and to improve next-day focus. It is also designed to complement Clarity, the first nootropic brought to market... - October 28, 2016 - Thrivous

Thrivous Announces Science Advisor Board

Thrivous, a human intelligence and vitality company, announces the formation of its science advisor board. The board will inform ongoing product and service development. Formation of the board reflects Thrivous' commitment to guidance from consensus science in its mission to help customers access... - October 28, 2016 - Thrivous

New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories

5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction. - October 24, 2016 - Life Science Strategy Group, LLC

Presentation from electroCore Shows That Healthcare Costs for Patients with a Primary Headache Diagnosis Cost Four Times More Than a Healthy Patient Due to Comorbidities

Research presented at the Academy of Managed Care Pharmacy (AMCP) Nexus in early October in Washington, DC, showed that 60 percent of adult patients who were diagnosed with primary headache had one or more comorbidities which raised the average annual cost of their healthcare to over $20,000. This... - October 22, 2016 - electroCore

Experimentica Ltd. Appoints New Director of In Vivo Pharmacology

Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately. Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental... - October 22, 2016 - Experimentica Ltd

Recent Headlines Within Biotechnology

Recent Headlines
Within Biotechnology